eli lilly glp-1 pipeline Latest Competitive Analysis of Drug GLP-1 agonist clinical pipeline 2026:

Primary concerns include additive cardiovascular effects (tachycardia, hypertension), intensified gastrointestinal symptoms (nausea, vomiting, constipation), central nervous system effects (insomnia, anxiety), and excessive appetite suppression potentially leading to nutritional deficiencies

Studies also show that stopping these medications typically results in significant weight gain, so long-term treatment is likely necessary.

When they are discontinued: A1C levels often rise Fasting blood sugar may increase Diabetes symptoms may return Thus, for patients with Type 2 diabetes, stopping a GLP-1 without an alternative treatment plan can increase the risk of worsening blood sugar control, making close medical supervision and proactive adjustments essential.2 Digestion Speeds Back Up Once you discontinue a GLP-1, your digestive system returns to its baseline rhythm: Food empties from the stomach more quickly Earlier hunger cues return Cravings may become harder to control Many patients find it helpful to follow structured eating guidance like the one outlined in our nutritional support program

chest tightness